Marc K. Wallack

2.6k total citations
109 papers, 2.0k citations indexed

About

Marc K. Wallack is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Marc K. Wallack has authored 109 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 36 papers in Immunology and 31 papers in Surgery. Recurrent topics in Marc K. Wallack's work include Immunotherapy and Immune Responses (36 papers), Virus-based gene therapy research (19 papers) and CAR-T cell therapy research (16 papers). Marc K. Wallack is often cited by papers focused on Immunotherapy and Immune Responses (36 papers), Virus-based gene therapy research (19 papers) and CAR-T cell therapy research (16 papers). Marc K. Wallack collaborates with scholars based in United States, Greece and India. Marc K. Wallack's co-authors include Alfred A. Bartolucci, Charles M. Balch, Stephanie F. Bernik, Les Rosen, Kirby I. Bland, Lawrence E. Flaherty, Marshall M. Urist, William A. Robinson, Jon Richards and Adam R. Kolker and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Marc K. Wallack

106 papers receiving 1.8k citations

Peers

Countries citing papers authored by Marc K. Wallack

Since Specialization

Citations

This map shows the geographic impact of Marc K. Wallack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc K. Wallack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc K. Wallack more than expected).

Fields of papers citing papers by Marc K. Wallack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc K. Wallack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc K. Wallack. The network helps show where Marc K. Wallack may publish in the future.

Co-authorship network of co-authors of Marc K. Wallack

This figure shows the co-authorship network connecting the top 25 collaborators of Marc K. Wallack. A scholar is included among the top collaborators of Marc K. Wallack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc K. Wallack. Marc K. Wallack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Covid-19 Delta variant resulting in multi system thromboembolic disease 2022 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), (unknown), Marc K. Wallack, (unknown)	2
2	Follow-up analysis of a randomized phase III immunotherapeutic clinical trial on melanoma 2013 ·Molecular and Clinical Oncology ·Robert Suriano, Shilpi Rajoria, Andrea L. George, Jan Geliebter, Raj K. Tiwari, Marc K. Wallack	10
3	Chopart's Amputation for Resection of Clear Cell Sarcoma of the Foot: A Case Report and Review of the Literature 2009 ·The Journal of Foot & Ankle Surgery ·(unknown), (unknown), (unknown), (unknown), Marc K. Wallack	2
4	The Changing Surgical Residency 2005 ·Current Surgery ·(unknown), (unknown), Marc K. Wallack	1
5	The 80-hour workweek 2004 ·Surgical Clinics of North America ·Brigid K. Killelea, (unknown), (unknown), Marc K. Wallack	17
6	Resident work hour regulations: comments from New York 2003 ·Current Surgery ·(unknown), Marc K. Wallack	3
7	Therapeutic effect of colon tumor cells expressing FLT-3 ligand plus systemic IL-2 in mice with syngeneic colon cancer 2002 ·Cancer Immunology Immunotherapy ·(unknown), Christos Stavropoulos, (unknown), (unknown), Marc K. Wallack	11
8	Intracolonic use of vancomycin for treatment of Clostridium difficile colitis in a patient with a diverted colon 2001 ·Diseases of the Colon & Rectum ·Daniel R. Nathanson, Malachi Sheahan, (unknown), Marc K. Wallack	19
9	Balloon Blunt-Tip Trocar for Laparoscopic Cholecystectomy: Improvement over the Traditional Hasson and Veress Needle Methods 2001 ·Journal of Laparoendoscopic & Advanced Surgical Techniques ·Thomas Bernik, Susan M. Trocciola, David Mayer, (unknown), Christopher J. Czura, Marc K. Wallack	13
10	Pedunculated Malignant Melanoma 2000 ·Dermatologic Surgery ·(unknown), Paul K. Chu, (unknown), Marc K. Wallack, Philip C. Don, Jeffrey M Weinberg	9
11	Carcinoma of the breast during pregnancy: a review and update on treatment options 1998 ·Surgical Oncology ·Stephanie F. Bernik, Thomas Bernik, Brian P. Whooley, Marc K. Wallack	23
12	Combinatorial Antibodies Against Human Malignant Melanoma 1997 ·Hybridoma ·(unknown), Patricia Van Belle, David E. Elder, Haruhiko Maruyama, Lutz Jacob, (unknown), Marc K. Wallack, Don L. Siegel, Dorothee Herlyn	24
13	Increased Survival of Patients Treated With a Vaccinia Melanoma Oncolysate Vaccine 1997 ·Annals of Surgery ·Marc K. Wallack, (unknown), (unknown), Palma M. Shaw, (unknown), Marshall M. Urist, Kirby I. Bland, D. Murray, William A. Robinson, Lawrence E. Flaherty, Jon Richards, Les Rosen, (unknown)	37
14	Adjuvant immunotherapy for patients with melanoma: Are patients with melanoma of the head and neck candidates for this therapy? 1997 ·Head & Neck ·Palma M. Shaw, (unknown), Stephanie F. Bernik, (unknown), Marc K. Wallack	7
15	Thoracoscopy in acquired immunodeficiency syndrome 1997 ·Journal of Thoracic and Cardiovascular Surgery ·David R. Flum, (unknown), Thomas Bernik, (unknown), (unknown), Peter X. Adams, Marc K. Wallack	6
16	Favorable clinical responses in subsets of patients from a randomized, multi-institutional melanoma vaccine trial 1996 ·Annals of Surgical Oncology ·Marc K. Wallack, (unknown), Brian P. Whooley, (unknown), Alfred A. Bartolucci	12
17	Immunotherapy of a Vaccinia Colon Oncolysate Prepared with Interleukin-2 Gene-Encoded Vaccinia Virus and Interferon-α Increases the Survival of Mice Bearing Syngeneic Colon Adenocarcinoma 1994 ·Journal of Immunotherapy ·Nobuyuki Tanaka, (unknown), Marc K. Wallack	6
18	Prospects for Gene Therapy and Lymphokine Therapy for Metastatic Melanoma 1992 ·Annals of Plastic Surgery ·(unknown), (unknown), (unknown), Marc K. Wallack	2
19	Vaccinia virus oncolysates in the treatment of malignant melanoma 1988 ·Cancer treatment and research ·Jerry A. Bash, Marc K. Wallack	5
20	Gestational carcinoma of the female breast 1983 ·Current Problems in Cancer ·Marc K. Wallack, (unknown), John M. Bedwinek, Alex E. Denes, Glenn P. Glasgow, (unknown), John S. Meyer, Lee A. Rigg, (unknown)	95

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact